ID
36029
Description
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the AE form. It has to be filled in if the subject experienced an AE during the study trial.
Keywords
Versions (1)
- 4/9/19 4/9/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
April 9, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Adverse Events
- StudyEvent: ODM
Description
Adverse Event
Alias
- UMLS CUI-1
- C0877248 (Adverse event)
- LOINC
- MTHU014542
Description
No adverse event
Data type
boolean
Description
Record any Adverse events (using standard medical terminology) observed or elicited by the following direct question to the subject: "Have you felt different in any way since starting the new treatment or since the last visit?" Provide the diagnosis NOT symptoms where possible. (One adverse event per column)
Data type
text
Alias
- UMLS CUI [1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
Description
Comment for GSK
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C0947611 (Comment)
- LOINC
- LP72293-1
- UMLS CUI [1,3]
- C0008961 (Clinical Investigators)
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C2985916 (Adverse Event Onset Date)
Description
00:00-23:59
Data type
time
Alias
- UMLS CUI [1,1]
- C0449244 (Time of onset)
- SNOMED
- 263501003
- UMLS CUI [1,2]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
Description
day month year (If ongoing, please leave blank)
Data type
date
Alias
- UMLS CUI [1,1]
- C0806020 (End date)
- SNOMED
- 454551000124105
- LOINC
- MTHU008302
- UMLS CUI [1,2]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
Description
00:00-23:59 (If ongoing, please leave blank)
Data type
time
Alias
- UMLS CUI [1,1]
- C1522314 (End Time)
- SNOMED
- 397898000
- UMLS CUI [1,2]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
Description
Outcome
Data type
integer
Alias
- UMLS CUI [1]
- C1705586 (Adverse Event Outcome)
Description
AE Event Course
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C0750729 (Course)
- SNOMED
- 288524001
Description
Number of Episodes
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C4086638 (Number of Episodes)
Description
MILD: An event which is easily tolerated MODERATE: An event which is sufficiently discomforting to interfere with daily activity SEVERE: An event which prevents normal everyday activities
Data type
integer
Alias
- UMLS CUI [1]
- C1710066 (Severity of Adverse Event)
Description
Action taken with respect to investigational drug
Data type
integer
Alias
- UMLS CUI [1]
- C2826626 (Adverse Event Action Taken with Study Treatment)
Description
NOT RELATED: The event is definitely not related to the study procedured UNLIKELY: There are other more likely causes and the study procedures are not suspected as a cause SUSPECTED (REASONABLE POSSIBILITY): A direct cause and effect relationship between the study procedures and the event has not been demonstrated but there is a reasonable possibility that the study procedures were involved PROBABLE: There probably is a direct cause and effect relationship between the event and the study procedures
Data type
integer
Alias
- UMLS CUI [1,1]
- C1518404 (Non-serious Adverse Event)
- UMLS CUI [1,2]
- C0013230 (Investigational New Drugs)
- UMLS CUI [1,3]
- C0439849 (Relationships)
- SNOMED
- 263498003
- LOINC
- LP146886-9
Description
If "Yes", please record on Concomitant Medication form.
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
Description
Subject withdrawn
Data type
text
Alias
- UMLS CUI [1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
Description
Investigator's Signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C2346576 (Investigator Signature)
- UMLS CUI [1,2]
- C0011008 (Date in time)
- SNOMED
- 410671006
Similar models
Adverse Events
- StudyEvent: ODM
C0947611 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
No comments